The Cannavore™ Wins Micron Waste Cannabis Digester Naming Contest

Ryan Allway

August 20th, 2018

News, Top News

VANCOUVER, Aug. 15, 2018 /CNW/ – Micron Waste Technologies Inc. (the “Company”) (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a leading developer of aerobic digester solutions for the treatment of organic food and cannabis waste, announced today The Cannavore™ name has won the Company’s Cannabis Waste Digester Naming Contest.

Micron Waste Technologies Inc. (CNW Group/Micron Waste Technologies Inc.)

The Cannavore name was chosen following a crowd-sourced contest which collected 2379 product name submissions from entrants in Canadaand the United States. The winning entry was selected by cannabis industry experts Cam Battley, Chief Corporate Officer for Aurora Cannabis Inc.; Noelle Skodzinski, Editorial Director, Cannabis Business Times, Cannabis Dispensary magazine and The Cannabis Conference; and James West, Editor and Publisher of the Midas Letter and the Midas Letter Live. Pending confirmation of compliance with contest rules regarding residency and age, the contest prize of $2,000 USD and an all-expenses paid trip for two to christen the first Cannavore digester at Aurora Cannabis Inc’s (“Aurora”) (TSX: ACB) Mountain facility outside Calgary, Alberta will go Jack Ponte of Ontario.

“We’d like to thank Mr. Ponte and everyone who entered the Digester Naming Contest,” said Micron President Alfred Wong. “The creativity of entries made choosing a winner very difficult, but The Cannavore edged out the competition with its combined cleverness, simplicity and originality.”

The Cannavore digester, an industrial-grade cannabis waste processor, pulverizes and renders plant waste in combination with a proprietary blend of microbes and enzymes designed and developed by Micron. Importantly, as part of Micron’s full-system waste treatment platform, effluent from the digester is further treated to derive clean greywater which can be re-used in growing operations. Alternatively, the treated regulatory-compliant greywater from The Cannavore digester, which meets municipal discharge standards, can be safely discharged. Active Pharmaceutical Compounds (ACBs) in cannabis waste are denatured on-site at cannabis cultivation facilities by a Micron-developed biotechnology process, eliminating risk of public and ecosystem exposure. ACB-free bio-solids from The Cannavore are saleable as livestock fodder.

The Company’s first Cannavore digester was delivered to Aurora’s Mountain facility on June 28, 2018. The 55,200 square foot cultivation and production facility produces 4,800 kg of premium cannabis each year over multiple production cycles. The Aurora Mountain Cannavore digester was the first of several to be commissioned by Aurora, subject to the technology meeting certain milestones per a collaboration agreement announced in December 2017.

“The Cannavore unit is progressing well through optimization of several distinct capabilities– cannabis waste digestion, wastewater extraction and purification, the denaturing of active pharmaceuticals and the calibration of all sensors and software, including remote operation,” said Micron Chief Technology Officer Dr. Bob Bhushan.

The Cannavore digester employs industry-specific computer software developed by Micron and BC Research Inc. to provide for logic, remote access, data management and equipment control. The software will allow Micron to co-pilot its units through real-time diagnostics and analysis at any location world-wide.

The Cannavore digester and its sister unit, the Organic Food Waste Digester, have been awarded an Industrial Design Certificate of Registrationfrom the Canadian Intellectual Property Office (CIPO). Micron sought and won 10-year intellectual property protection for innovative features unique to Micron’s unit, which processes both food waste and cannabis plant waste on a commercial scale. The Company’s design patent is also pending in the United States.

Both the Cannavore digester and the Organic Food Waste Digester systems were developed based on R&D from Micron’s environmentally-sound, propriety biomass waste processing platform, which realizes up to 35% in cost efficiencies and emits 58% fewer greenhouse gas emissions than conventional waste management methods. The comprehensive regulatory-compliant, clean technology systems have been engineered to operate on-site where needed in a contained unit which does not emit sound or smell, while exempting customers from the need to haul, incinerate or landfill waste.

About Micron Waste Technologies Inc.
Micron Waste Technologies Inc is a well-funded technology company with over $6 million in working capital. The Company’s organic waste management system processes organic waste directly on-site and treats the resulting waste water into clean water which meets municipal sewage discharge standards. The treated water can be discharged directly into the sewer or recycled back into industrial or agricultural operations. The Company has developed the world’s first Cannabis Waste Digester, The Cannavore digester, which also denatures Active Pharmaceutical Compounds from waste streams. Please visit our website at www.micronwaste.com for further information. Micron is a public company with listings on the CSE: MWM, OTC: MICWF, and in Frankfurt: 7FM2.

On Behalf of the Board
Rav Mlait
Chief Executive Officer and Director

The Exchange does not accept responsibility for the adequacy or accuracy of this release

FORWARD LOOKING STATEMENTS:
The forward-looking information contained in this press release is made as of the date of this press release and, except as required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by law. By its very nature, such forward-looking information requires the Company to make assumptions that may not materialize or that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information.

SOURCE Micron Waste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/15/c7710.html

Media Inquiries: Karen Lauriston, +1.905.691.1185, karen@micronwaste.com; Investor Relations, +1.844.318.8216, info@micronwaste.com, www.micronwaste.comCopyright CNW Group 2018

Source: Canada Newswire (August 15, 2018 – 7:00 AM EDT)

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Search CannabisFN

Press Coverage

Psychedelics Index

Visit the CFN Video Library

Join Our Facebook Page

Top Videos

CFN Media / Paul Rosen

Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]

Matthew Nordgren of ARCADIAN Fund

Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]

Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.

CB Therapeutics Inc.

CB Therapeutics, Inc. is a biotechnology company focusing on the innovative production of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems.

Network Partners

Follow Us on Social Media

Facebook

Twitter

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.